Found 7 matching trials
Safety and Immunogenicity Study of AERAS-456 Vaccine for Tuberculosis
PHASE1This is a Phase I, open-label, dose-escalation study with three study group...
Location
SATVI Project Office, Brewelskloof Hospital
A Phase II Study of H56:IC31 in Healthy Adolescents
PHASE2This clinical trial will evaluate safety, immunogenicity, and efficacy (pre...
Location
Aurum Institute - Klerksdorp
Therapeutic Vaccination and Immune Modulation - New Treatment Strategies for the MDR Tuberculosis Pandemic
PHASE1Tuberculosis (TB) is a global challenge and for the increasing epidemic of ...
Location
Haukeland University Hospital
Study to Evaluate H56:IC31 in Preventing Rate of TB Recurrence
PHASE2This is a phase 2, double-blind, randomized (1:1), placebo-controlled trial...
Location
Task Clinical Research Centre
A Phase I Study of Safety & Immunogenicity of AERAS-456 in HIV-Neg. Adults Treated for Drug-susceptible Pulmonary TB
PHASE1This is a Phase I, double-blind, randomized, placebo-controlled safety and ...
Location
Task Clinical Research Centre
A Phase I/IIa AERAS-456 in HIV-Negative Adults With & Without Latent Tuberculosis Infection (C-035-456)
PHASE1This is a Phase I/IIa, double-blind, randomized, placebo-controlled, dose- ...
Location
eKhayavac TB Vaccine Trial
Safety and Immunogenicity Study of BCG, H4:IC31, and H56:IC31 Revaccination in Healthy Adolescents
PHASE1The aims of the phase 1b trial described here are to facilitate identificat...
Location
Desmond Tutu HIV Foundation